The efficacy and safety of anamorelin among patients with diabetes.
Ando K, Naito T, Hamauchi S, Miura K, Nishibori Y, Tonsho A, Matsuda S, Morita M, Sekikawa M, Doshita K, Kodama H, Yabe M, Morikawa N, Iida Y, Mamesaya N, Kobayashi H, Ryo K, Wakuda K, Ono A, Kenmotsu H, Murakami H, Yamazaki K, Takahashi T.
Ando K, et al. Among authors: morita m.
Int J Clin Oncol. 2024 May 9. doi: 10.1007/s10147-024-02546-8. Online ahead of print.
Int J Clin Oncol. 2024.
PMID: 38722487